Year-over-year earnings per share growth for the last twelve months: vcel.com (VCEL)

Vericel Inc. - graphic logo of issuer VCEL

Vericel Corporation (VCEL) provides climate-controlled express delivery of living tissues to ensure successful surgical outcomes. The company leads in regenerative medicine, investing in cartilage and skin bioengineering. Strict biosafety and waste disposal regulations are maintained. The current quarterly EPS growth value demonstrates efficiency dynamics, where 174.20 reflects the latest metric value.

VCEL: vcel.com Year-over-year earnings per share growth for the last twelve months 07/04/2022 - 11/15/2026

Vericel Corporation (VCEL) - metric breakdowns and financial figures

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Vericel Inc. - VCEL
Manufactured product of Vericel Inc.

Vericel Corporation (VCEL) maintains high business margins through monopoly pricing on its unique cell therapies. The indicator's algorithm aggregates the net increase in share value, accounting for the impact of fiscal adjustments and subsidies. This metric measures operational efficiency and the speed of profit capitalization between reporting periods, allowing investors to assess the risk of capital freeze in the event of a shift in tax policy. By analyzing the quarterly earnings per share trend on GURU.Markets, one can verify the sustainability of the issuer's returns.

Main competitors

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months ORKA (orukatx.com)|Year-over-year earnings per share growth for the last twelve months Sanara (SMTI)|DBV Technologies - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Solesence SLSN|journeymedicalcorp.com (DERM) - Earnings per share growth in annualized terms for the last twelve months|FBRX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months EMPG|SLGL (sol-gel.com) - Year-over-year net earnings per share growth for the last 12 months|AXIL (AXIL Brands, Inc.) - Year-over-year earnings per share growth for the last twelve months|MDCX (Medicus Pharma Corp) - Quarterly EPS earnings growth|Verrica Pharmaceuticals (VRCA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HOTH (Hoth Therapeutics, Inc.)|BFRI - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics)|Year-over-year earnings per one share growth for the last 12 months SNOA|Quoin Pharmaceuticals Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Azitra Corporation AZTR|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|Elevai Labs Inc. (ELAB) - Quarterly EPS earnings growth|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth